Bracanat 150 Tablet is primarily used for maintenance therapy in ovarian cancer, particularly in patients who have BRCA gene mutations and have responded to platinum-based chemotherapy. It belongs to a class of medicines known as PARP (poly ADP-ribose polymerase) inhibitors, which represent an important advancement in targeted cancer therapy.
This medicine should be taken exactly as prescribed by your oncologist, who will determine the appropriate dosage based on your condition. You should inform your doctor about any pre-existing conditions or ongoing medications before beginning this medicine. If you notice any side effects while taking this medicine, notify your doctor immediately. Continue taking the medicine for the full duration prescribed by your doctor for optimal results.